The development of peptide-based drugs, which are usually synthetic analogues of
endogenous peptides, is currently one of the most topical directions in drug development …

Peptides make up only a fraction of therapeutically beneficial pharmaceutical molecules that
are either in clinical testing or in the market. Despite the initially low number and impact of …

Conventional chemotherapeutic drugs have significant limitations. For example, tumors may
develop resistance, cancers may relapse after treatment, and the drugs may induce …

Highlights•Peptides from three distinct groups are important for cancer therapy and
diagnostics.•Anticancer peptides are most frequently mimics of natural proteins and …

Cancer is one of the leading causes of death worldwide. Conventional cancer therapies
mainly focus on mass cell killing without high specificity and often cause severe side effects …

Background: Peptide-based pharmaceuticals have recently experienced a renaissance due
to their ability to fill the gap between the two main classes of available drugs, small …

Human cancer remains a cause of high mortality throughout the world. The conventional
methods and therapies currently employed for treatment are followed by moderate-to-severe …

Several proteins and peptides have therapeutic potential and can be used for cancer
therapy. By binding to cell surface receptors and other indicators uniquely linked with or …

Peptides are increasingly being developed for use as therapeutics to treat many ailments,
including cancer. Therapeutic peptides have the advantages of target specificity and low …

Background Nowadays, conventional medical treatments such as surgery, radiotherapy, and
chemotherapy cannot cure all types of cancer. A promising approach to treat solid tumors is …